Aviva
ONC

Aviva’s BeOne Medicines Ltd ONC Stock Holding History

Aviva’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,649
Closed -$3.46M – 1035
2022
Q3 		$3.46M Buy
25,649
+1,200
+5% +$206K 0.02% 625
2022
Q2 		$3.96M Buy
24,449
+2,700
+12% +$422K 0.02% 630
2022
Q1 		$4.1M Buy
21,749
+200
+0.9% +$42.5K 0.02% 626
2021
Q4 		$5.84M Buy
21,549
+5,100
+31% +$1.72M 0.02% 545
2021
Q3 		$5.97M Buy
16,449
+2,619
+19% +$856K 0.03% 530
2021
Q2 		$4.75M Sell
13,830
-300
-2% -$99.4K 0.02% 604
2021
Q1 		$4.92M Sell
14,130
-600
-4% -$199K 0.02% 538
2020
Q4 		$3.81M Sell
14,730
-3,744
-20% -$1.03M 0.02% 552
2020
Q3 		$5.29M Buy
18,474
+1,449
+9% +$341K 0.03% 436
2020
Q2 		$3.21M Buy
17,025
+163
+1% +$26.5K 0.02% 521
2020
Q1 		$2.08M Buy
16,862
+1,304
+8% +$204K 0.02% 725
2019
Q4 		$2.58M Buy
15,558
+305
+2% +$50.7K 0.02% 612
2019
Q3 		$1.87M Sell
15,253
-1,449
-9% -$192K 0.01% 656
2019
Q2 		$2.07M Buy
16,702
+1,775
+12% +$225K 0.01% 651
2019
Q1 		$1.97M Buy
14,927
+166
+1% +$22.4K 0.01% 657
2018
Q4 		$2.07M Buy
+14,761
New +$1.96M 0.02% 627

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aviva's ONC Position: Q4 2022 in Review

Aviva sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 25,649 shares — an estimated $3.46M sold.

Aviva first reported a position in ONC in Q4 2018 and held it in 16 quarters. The position peaked at $5.97M in Q3 2021. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • Aviva reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • Aviva sold 25,649 BeOne Medicines Ltd shares in Q4 2022, an estimated $3.46M.
  • Aviva first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 16 quarters.
  • Aviva's BeOne Medicines Ltd position peaked at $5.97M in Q3 2021.
  • 212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on Aviva's 13F filing for Q4 2022, filed 9 Feb 2023.